Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis

被引：20

作者：

Cho, Soo-Kyung ^{[1
]}

Oh, Il Hwan ^{[1
]}

Park, Chan Kum ^{[2
]}

Bae, Sang-Cheol ^{[1
]}

Sung, Yoon-Kyoung ^{[1
]}

机构：

[1] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 133792, South Korea

[2] Hanyang Univ, Dept Pathol, Seoul 133792, South Korea

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 04期

关键词：

Etanercept; Rheumatoid arthritis; Organizing pneumonia; ALPHA THERAPY;

D O I：

10.1007/s00296-009-1350-4

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

TNF inhibitors are being used in a rapidly expanding number of rheumatoid arthritis (RA) patients due to their effectiveness and acceptable safety profiles. To date, concerns regarding the adverse effects of TNF inhibitors have focused on infections, hematologic malignancies, and demyelinating disorders. Recently, the development of autoantibodies and other autoimmunity has been increasingly reported. Here, we describe a 36-year-old RA patient in whom organizing pneumonia and systemic lupus erythematosus were detected during etanercept treatment.

引用

页码：1055 / 1057

页数：3

共 11 条

[1]

Anti-TNFα therapy in rheumatoid arthritis and autoimmunity [J].

Caramaschi, P ;

Biasi, D ;

Colombatti, M ;

Pieropan, S ;

Martinelli, N ;

Carletto, A ;

Volpe, A ;

Pacor, L ;

Bambara, L .

RHEUMATOLOGY INTERNATIONAL, 2006, 26 (03) :209-214

[2]

Cryptogenic organising pneumonia [J].

Cordier, J. -F. .

EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (02) :422-446

[3]

Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during bucillamine treatment for rheumatoid arthritis [J].

Kajiya, Takashi ;

Kuroda, Atsushi ;

Hokonohara, Daisuke ;

Tei, Chuwa .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2006, 332 (01) :39-42

[4]

Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO

[5]

2-W

[6]

Moreland LW, 2006, J RHEUMATOL, V33, P854

[7]

Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial [J].

Moreland, LW ;

Schiff, MH ;

Baumgartner, SW ;

Tindall, EA ;

Fleischmann, RM ;

Bulpitt, KJ ;

Weaver, AL ;

Keystone, EC ;

Furst, DE ;

Mease, PJ ;

Ruderman, EM ;

Horwitz, DA ;

Arkfeld, DG ;

Garrison, L ;

Burge, DJ ;

Blosch, CM ;

Lange, MLM ;

McDonnell, ND ;

Weinblatt, ME .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :478-+

[8]

A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature [J].

Mori, Shunsuke ;

Cho, Isamu ;

Koga, Yukinori ;

Sugimoto, Mineharu .

MODERN RHEUMATOLOGY, 2008, 18 (01) :60-66

[9]

Autoimmune diseases induced by TNF-targeted therapies [J].

Ramos-Casals, Manuel ;

Brito-Zeron, Pilar ;

Soto, Maria-Jose ;

Cuadrado, Maria-Jose ;

Khamashta, Munther A. .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2008, 22 (05) :847-861

[10]

The organizing pneumonias: an update and review [J].

Schlesinger, C ;

Koss, MN .

CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (05) :422-430

← 1 2 →